申请人:Concert Pharmaceuticals, Inc.
公开号:US20170334937A1
公开(公告)日:2017-11-23
This invention relates to compounds of Formula (A), and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a viral DNA polymerase inhibitor.